BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28027931)

  • 1. Copper chaperone Atox1 plays role in breast cancer cell migration.
    Blockhuys S; Wittung-Stafshede P
    Biochem Biophys Res Commun; 2017 Jan; 483(1):301-304. PubMed ID: 28027931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Copper Chaperone Atox1 Translocates to the Nucleus but does not Bind DNA In Vitro.
    Kahra D; Mondol T; Niemiec MS; Wittung-Stafshede P
    Protein Pept Lett; 2015; 22(6):532-8. PubMed ID: 25962064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copper Transport Protein Antioxidant-1 Promotes Inflammatory Neovascularization via Chaperone and Transcription Factor Function.
    Chen GF; Sudhahar V; Youn SW; Das A; Cho J; Kamiya T; Urao N; McKinney RD; Surenkhuu B; Hamakubo T; Iwanari H; Li S; Christman JW; Shantikumar S; Angelini GD; Emanueli C; Ushio-Fukai M; Fukai T
    Sci Rep; 2015 Oct; 5():14780. PubMed ID: 26437801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of New Potential Interaction Partners for Human Cytoplasmic Copper Chaperone Atox1: Roles in Gene Regulation?
    Öhrvik H; Wittung-Stafshede P
    Int J Mol Sci; 2015 Jul; 16(8):16728-39. PubMed ID: 26213915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-cell tracking demonstrates copper chaperone Atox1 to be required for breast cancer cell migration.
    Blockhuys S; Zhang X; Wittung-Stafshede P
    Proc Natl Acad Sci U S A; 2020 Jan; 117(4):2014-2019. PubMed ID: 31932435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thiol-based copper handling by the copper chaperone Atox1.
    Hatori Y; Inouye S; Akagi R
    IUBMB Life; 2017 Apr; 69(4):246-254. PubMed ID: 28294521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conserved residues modulate copper release in human copper chaperone Atox1.
    Hussain F; Olson JS; Wittung-Stafshede P
    Proc Natl Acad Sci U S A; 2008 Aug; 105(32):11158-63. PubMed ID: 18685091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATOX1 gene silencing increases susceptibility to anticancer therapy based on copper ionophores or chelating drugs.
    Barresi V; Spampinato G; Musso N; Trovato Salinaro A; Rizzarelli E; Condorelli DF
    J Inorg Biochem; 2016 Mar; 156():145-52. PubMed ID: 26784148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An expanding range of functions for the copper chaperone/antioxidant protein Atox1.
    Hatori Y; Lutsenko S
    Antioxid Redox Signal; 2013 Sep; 19(9):945-57. PubMed ID: 23249252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended functional repertoire for human copper chaperones.
    Matson Dzebo M; Ariöz C; Wittung-Stafshede P
    Biomol Concepts; 2016 Feb; 7(1):29-39. PubMed ID: 26745464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redox sulfur chemistry of the copper chaperone Atox1 is regulated by the enzyme glutaredoxin 1, the reduction potential of the glutathione couple GSSG/2GSH and the availability of Cu(I).
    Brose J; La Fontaine S; Wedd AG; Xiao Z
    Metallomics; 2014 Apr; 6(4):793-808. PubMed ID: 24522867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants for simultaneous binding of copper and platinum to human chaperone Atox1: hitchhiking not hijacking.
    Palm-Espling ME; Andersson CD; Björn E; Linusson A; Wittung-Stafshede P
    PLoS One; 2013; 8(7):e70473. PubMed ID: 23936210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The C-Terminus of Human Copper Importer Ctr1 Acts as a Binding Site and Transfers Copper to Atox1.
    Kahra D; Kovermann M; Wittung-Stafshede P
    Biophys J; 2016 Jan; 110(1):95-102. PubMed ID: 26745413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copper-transfer mechanism from the human chaperone Atox1 to a metal-binding domain of Wilson disease protein.
    Rodriguez-Granillo A; Crespo A; Estrin DA; Wittung-Stafshede P
    J Phys Chem B; 2010 Mar; 114(10):3698-706. PubMed ID: 20166696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enthalpy-entropy compensation at play in human copper ion transfer.
    Niemiec MS; Dingeldein AP; Wittung-Stafshede P
    Sci Rep; 2015 May; 5():10518. PubMed ID: 26013029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Copper chaperone antioxidant 1: multiple roles and a potential therapeutic target.
    Yang D; Xiao P; Qiu B; Yu HF; Teng CB
    J Mol Med (Berl); 2023 May; 101(5):527-542. PubMed ID: 37017692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human cytoplasmic copper chaperones Atox1 and CCS exchange copper ions in vitro.
    Petzoldt S; Kahra D; Kovermann M; Dingeldein AP; Niemiec MS; Ådén J; Wittung-Stafshede P
    Biometals; 2015 Jun; 28(3):577-85. PubMed ID: 25673218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue localization of the copper chaperone ATOX1 and its potential role in disease.
    Moore SD; Helmle KE; Prat LM; Cox DW
    Mamm Genome; 2002 Oct; 13(10):563-8. PubMed ID: 12420134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal Structure of the Human Copper Chaperone ATOX1 Bound to Zinc Ion.
    Mangini V; Belviso BD; Nardella MI; Natile G; Arnesano F; Caliandro R
    Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ctr1 Intracellular Loop Is Involved in the Copper Transfer Mechanism to the Atox1 Metallochaperone.
    Levy AR; Nissim M; Mendelman N; Chill J; Ruthstein S
    J Phys Chem B; 2016 Dec; 120(48):12334-12345. PubMed ID: 27934216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.